Physician profile
Yolanda Hendley
NPI 1811041080
$3,406.61
in general payments reported to CMS, 2019-2025
24 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $229 · 2021: $362 · 2022: $884 · 2023: $356 · 2024: $490 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $845.47 | 2019-2025 | Camzyos, Eliquis |
| Inari Medical, INC. | $815.28 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $288.19 | 2019-2023 | Brilinta |
| Abbott Laboratories | $259.41 | 2021-2025 | Cardiomems, Aveir, Nc Trek Neo |
| Janssen Pharmaceuticals, INC | $199.11 | 2019-2023 | Xarelto |
| Medtronic, INC. | $141.15 | 2024-2025 | Corevalve Evolut R, Linq II, Symplicity G3 |
| Novo Nordisk INC | $110.66 | 2025 | |
| Terumo Medical Corporation | $83.68 | 2019-2023 | Glidewire, Heartrail |
| Boston Scientific Corporation | $79.42 | 2019 | |
| Biotronik INC. | $72.20 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.72 | 2019 | |
| Stryker Corporation | $67.62 | 2025 | Flowtriever |
| Amarin Pharma, INC. | $60.37 | 2019-2020 | |
| Scpharmaceuticals INC. | $54.78 | 2025 | |
| Preventice Services, LLC | $49.12 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $49.06 | 2019-2021 | |
| Akcea Therapeutics, INC. | $29.57 | 2019 | |
| Cardiovascular Systems INC. | $23.39 | 2022 | |
| Philips North America LLC | $21.54 | 2021 | |
| Heartflow, INC. | $19.38 | 2025 | |
| Lantheus Medical Imaging, INC. | $19.14 | 2021 | |
| Kestra Medical Technology Services, INC. | $18.78 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $16.23 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yolanda Hendley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.